Arkolith/Insider Trading/WST/Form 4

McMahon Robert W.

SVP & Chief Financial OfficerWEST PHARMACEUTICAL SERVICES INC (WST) · full profile →Form 4 · filed Feb 12, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2026Tax withholding(F)1K$246.16$308K3K
Feb 11, 2026Option exercise(M)4K——4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 11, 2026Option exercise(M)4K—$08K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000105770-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML